Cargando…
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
The dominant hypothesis of Alzheimer’s disease (AD) aetiology, the neuropathological guidelines for diagnosing AD and the majority of high-profile therapeutic efforts, in both research and in clinical practice, have been built around one possible causal factor, amyloid-β (Aβ). However, the causal li...
Autores principales: | Morris, Gary P., Clark, Ian A., Vissel, Bryce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208728/ https://www.ncbi.nlm.nih.gov/pubmed/30349969 http://dx.doi.org/10.1007/s00401-018-1918-8 |
Ejemplares similares
-
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
por: Morris, Gary P, et al.
Publicado: (2014) -
Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer’s disease
por: Clark, I A, et al.
Publicado: (2015) -
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
por: Weller, Roy O, et al.
Publicado: (2009) -
Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α‐synuclein, amyloid‐β and insulin resistance in neurodegenerative diseases
por: Clark, I A, et al.
Publicado: (2018) -
Inflammation-sleep interface in brain disease: TNF, insulin, orexin
por: Clark, Ian A, et al.
Publicado: (2014)